Sunzen Biotech Bhd Stock Price To Earnings To Growth
| 0148 Stock | 0.32 0.01 3.23% |
Sunzen Biotech Bhd fundamentals help investors to digest information that contributes to Sunzen Biotech's financial success or failures. It also enables traders to predict the movement of Sunzen Stock. The fundamental analysis module provides a way to measure Sunzen Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sunzen Biotech stock.
Sunzen |
Sunzen Biotech Bhd Company Price To Earnings To Growth Analysis
Sunzen Biotech's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Sunzen Biotech Bhd has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the Consumer Non-Cyclicals average (which is currently at 0.0) sector and about the same as Food & Tobacco (which currently averages 0.0) industry. This indicator is about the same for all Malaysia stocks average (which is currently at 0.0).
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Sunzen Fundamentals
| Return On Equity | 2.91 | |||
| Current Valuation | 128.73 M | |||
| Price To Book | 1.22 X | |||
| Price To Sales | 1.34 X | |||
| Revenue | 90.48 M | |||
| EBITDA | 6.57 M | |||
| Net Income | 3.71 M | |||
| Total Debt | 5.08 M | |||
| Cash Flow From Operations | (16.36 M) | |||
| Market Capitalization | 147.73 M | |||
| Total Asset | 148.71 M | |||
| Z Score | 17.4 | |||
| Net Asset | 148.71 M |
About Sunzen Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sunzen Biotech Bhd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sunzen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sunzen Biotech Bhd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sunzen Stock
Sunzen Biotech financial ratios help investors to determine whether Sunzen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sunzen with respect to the benefits of owning Sunzen Biotech security.